| Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE (NCT00687609) | Eli Lilly and Company | 2008-09-01 |
| Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo (NCT00762411) | Eli Lilly and Company | 2008-09-01 |
| Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer (NCT00703326) | Eli Lilly and Company | 2008-08-06 |
| A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer (NCT00683475) | Eli Lilly and Company | 2008-08-01 |
| A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma (NCT00415155) | Eli Lilly and Company | 2008-08-01 |
| Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia (NCT00718159) | Eli Lilly and Company | 2008-08-01 |
| Study of Ramucirumab in Ovarian Cancer (NCT00721162) | Eli Lilly and Company | 2008-08-01 |
| Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes (NCT00481117) | Eli Lilly and Company | 2008-08-01 |
| A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin (NCT00734474) | Eli Lilly and Company | 2008-08-01 |
| A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer (NCT00728949) | Eli Lilly and Company | 2008-08-01 |
| A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes. (NCT00734604) | Eli Lilly and Company | 2008-08-01 |
| A Phase 1b Trial in Patients With Renal Cell Cancer (NCT01258348) | Eli Lilly and Company | 2008-07-01 |
| A Safety Study in Participants With Advanced Solid Tumors (NCT01284335) | Eli Lilly and Company | 2008-07-01 |
| A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma (NCT00718419) | Eli Lilly and Company | 2008-07-01 |
| A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma (NCT00668148) | Eli Lilly and Company | 2008-07-01 |
| A Study for Participants With Metastatic Renal Cell Carcinoma (NCT00709995) | Eli Lilly and Company | 2008-06-30 |
| A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations (NCT00702650) | Eli Lilly and Company | 2008-06-01 |
| A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy (NCT00689728) | Eli Lilly and Company | 2008-06-01 |
| A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects (NCT00699998) | Eli Lilly and Company | 2008-06-01 |
| Fibromyalgia Health Outcome Study on Cost of Treatments (NCT00725101) | Eli Lilly and Company | 2008-06-01 |
| Switching to Duloxetine in Patients With Depression (NCT00696774) | Eli Lilly and Company | 2008-06-01 |
| A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia (NCT00673452) | Eli Lilly and Company | 2008-06-01 |
| A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00700427) | Eli Lilly and Company | 2008-06-01 |
| A Study for Teriparatide in Severe Osteoporosis (NCT00696644) | Eli Lilly and Company | 2008-06-01 |
| A Study of LY2541546 in Healthy Postmenopausal Women (NCT01742078) | Eli Lilly and Company | 2008-06-01 |
| A Study for Patients With Acute Leukemia (NCT01214655) | Eli Lilly and Company | 2008-06-01 |
| Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults (NCT00763724) | Eli Lilly and Company | 2008-06-01 |
| A Study of LY2624803 in Participants With Transient Insomnia (NCT01779830) | Eli Lilly and Company | 2008-05-01 |
| A Dose-Escalation Study for Patients With Advanced Cancer (NCT01214642) | Eli Lilly and Company | 2008-05-01 |
| A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression (NCT00666757) | Eli Lilly and Company | 2008-05-01 |
| Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast (NCT00664534) | Eli Lilly and Company | 2008-04-01 |
| A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients (NCT00666718) | Eli Lilly and Company | 2008-04-01 |
| Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3) (NCT00642174) | Eli Lilly and Company | 2008-04-01 |
| A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus (NCT00630825) | Eli Lilly and Company | 2008-04-01 |
| A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00620321) | Eli Lilly and Company | 2008-03-01 |
| A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia (NCT00640510) | Eli Lilly and Company | 2008-03-01 |
| A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer (NCT00642018) | Eli Lilly and Company | 2008-03-01 |
| A Long-term Study for the Treatment of Painful Diabetic Neuropathy (NCT00641719) | Eli Lilly and Company | 2008-03-01 |
| A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes (NCT01606397) | Eli Lilly and Company | 2008-03-01 |
| Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia (NCT00607919) | Eli Lilly and Company | 2008-03-01 |
| Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck (NCT00617734) | Eli Lilly and Company | 2008-03-01 |
| Effect of LY450139 on the Long Term Progression of Alzheimer's Disease (NCT00594568) | Eli Lilly and Company | 2008-03-01 |
| Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock (NCT00604214) | Eli Lilly and Company | 2008-03-01 |
| Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer (NCT00623233) | Eli Lilly and Company | 2008-03-01 |
| Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00636818) | Eli Lilly and Company | 2008-03-01 |
| Back Pain in Patients With Severe Osteoporosis (NCT00761332) | Eli Lilly and Company | 2008-02-01 |
| Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer (NCT00612586) | Eli Lilly and Company | 2008-02-01 |
| A Phase 1 Study in Patients With Solid Tumors (NCT01215916) | Eli Lilly and Company | 2008-02-01 |
| Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy (NCT00627042) | Eli Lilly and Company | 2008-02-01 |
| A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer (NCT00609518) | Eli Lilly and Company | 2008-02-01 |
| Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed (NCT00618748) | Eli Lilly and Company | 2008-02-01 |
| A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NCT00606021) | Eli Lilly and Company | 2008-01-01 |
| A Dose-Escalation Study in Participants With Advanced Cancer (NCT01524224) | Eli Lilly and Company | 2008-01-01 |
| Safety Study of Atomoxetine and Cerebrovascular Outcomes (NCT00634439) | Eli Lilly and Company | 2008-01-01 |
| Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy (NCT00577863) | Eli Lilly and Company | 2008-01-01 |
| A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers (NCT00414960) | Eli Lilly and Company | 2007-12-01 |
| A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma (NCT00533702) | Eli Lilly and Company | 2007-11-01 |
| Treatment Compliance in Children and Adolescents on ADHD Medication (NCT00540826) | Eli Lilly and Company | 2007-11-01 |
| A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide (NCT00557310) | Eli Lilly and Company | 2007-11-01 |
| Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide (NCT00560417) | Eli Lilly and Company | 2007-11-01 |
| The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants (NCT01606423) | Eli Lilly and Company | 2007-11-01 |
| A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma (NCT00515697) | Eli Lilly and Company | 2007-11-01 |
| Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas (NCT00586508) | Eli Lilly and Company | 2007-11-01 |
| A Study for the Treatment of Diabetic Peripheral Neuropathic Pain (NCT00552175) | Eli Lilly and Company | 2007-11-01 |
| Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer (NCT00536939) | Eli Lilly and Company | 2007-11-01 |
| A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer (NCT00550173) | Eli Lilly and Company | 2007-11-01 |
| A Study for Type 2 Diabetic Patients (NCT00548808) | Eli Lilly and Company | 2007-11-01 |
| A Study for Patients With Non-Hodgkin's Lymphomas (NCT00542919) | Eli Lilly and Company | 2007-11-01 |
| A Study of LY2090314 in Patients With Advanced or Metastatic Cancer (NCT01287520) | Eli Lilly and Company | 2007-11-01 |
| Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months (NCT00561509) | Eli Lilly and Company | 2007-11-01 |
| Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00568685) | Eli Lilly and Company | 2007-11-01 |
| Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy (NCT00533429) | Eli Lilly and Company | 2007-10-01 |
| Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer (NCT00475657) | Eli Lilly and Company | 2007-10-01 |
| Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00520676) | Eli Lilly and Company | 2007-10-01 |
| Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00546910) | Eli Lilly and Company | 2007-10-01 |
| A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations (NCT00857961) | Eli Lilly and Company | 2007-10-01 |
| Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma (NCT00509821) | Eli Lilly and Company | 2007-10-01 |
| Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men (NCT00540124) | Eli Lilly and Company | 2007-10-01 |
| An Observational Study Evaluating Patient Satisfaction and Quality of Life Associated With Switching Insulin (NCT00549887) | Eli Lilly and Company | 2007-09-01 |
| A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients (NCT00536471) | Eli Lilly and Company | 2007-09-01 |
| A Study of Pemetrexed in Children With Recurrent Cancer (NCT00520936) | Eli Lilly and Company | 2007-09-01 |
| Performance Status During Treatment With Pemetrexed in Patients With NSCLC (NCT00540241) | Eli Lilly and Company | 2007-09-01 |
| Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer (NCT00530621) | Eli Lilly and Company | 2007-09-01 |
| Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD) (NCT00530335) | Eli Lilly and Company | 2007-09-01 |
| Chemotherapy for Patients With Osteosarcoma (NCT00523419) | Eli Lilly and Company | 2007-09-01 |
| A Study for Patients With Schizophrenia (NCT00520923) | Eli Lilly and Company | 2007-09-01 |
| Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) (NCT00494026) | Eli Lilly and Company | 2007-09-01 |
| Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo (NCT00538681) | Eli Lilly and Company | 2007-09-01 |
| Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE) (NCT00510952) | Eli Lilly and Company | 2007-08-01 |
| Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) (NCT00494013) | Eli Lilly and Company | 2007-08-01 |
| Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer (NCT00520481) | Eli Lilly and Company | 2007-08-01 |
| Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder (NCT00529789) | Eli Lilly and Company | 2007-08-01 |
| Study of IMC-11F8 in Participants With Colorectal Cancer (NCT00835185) | Eli Lilly and Company | 2007-08-01 |
| Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes (NCT00510276) | Eli Lilly and Company | 2007-08-01 |
| Olanzapine Treatment of Patients With Bipolar I Disorder (NCT00510146) | Eli Lilly and Company | 2007-08-01 |
| A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma (NCT00490451) | Eli Lilly and Company | 2007-08-01 |
| A Study for Participants With Advanced Cancer (NCT01214629) | Eli Lilly and Company | 2007-07-01 |
| A Study for Patients With Type 2 Diabetes Mellitus (NCT00490854) | Eli Lilly and Company | 2007-07-01 |
| Duloxetine - Warfarin Pharmacodynamic Study (NCT00533026) | Eli Lilly and Company | 2007-07-01 |
| Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis (NCT00503399) | Eli Lilly and Company | 2007-07-01 |